AstraZeneca Names A New Head Of Business Development & Licensing
This article was originally published in The Pink Sheet Daily
Executive Summary
Shaun Grady becomes licensing head at AstraZeneca to replace the retiring John Goddard, but in an unusual move, will report to the CFO.
You may also be interested in...
At PSA, Meet The New Deal-Makers (Part 1)
Two of the biopharma industry's newest heads of business development talked with Elsevier Business Intelligence Editor-in-Chief Chris Morrison at the Pharmaceutical Strategic Alliances conference on Sept. 22 in New York.
At PSA, Meet The New Deal-Makers (Part 1)
Two of the biopharma industry's newest heads of business development talked with Elsevier Business Intelligence Editor-in-Chief Chris Morrison at the Pharmaceutical Strategic Alliances conference on Sept. 22 in New York.
People In The News: Tracking The Latest Industry Personnel Moves
Presidents and CEOs